Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04684719 · ClinicalTrials.gov registry record · Phase 3
Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial
A Phase 3 study of Traumatic Injury and Hemorrhagic Shock, sponsored by Jason Sperry.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,020
- Enrollment target
- 10
- Study locations
NCT04684719: Completed Phase 3 study of Traumatic Injury and Hemorrhagic Shock, sponsored by Jason Sperry.
NCT04684719 is a Phase 3 study of Traumatic Injury and Hemorrhagic Shock that has completed, run by Jason Sperry. The registered enrollment target is 1,020 participants, above the 294-participant average among 7 other Traumatic Injury trials with a reported enrollment target (247% higher). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04684719, a Phase 3 study of Traumatic Injury and Hemorrhagic Shock, has completed, sponsored by Jason Sperry.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,020 participants
- Enrollment target
- 10
- Study locations
Study Summary
Open label, multi-center, pre-hospital randomized trial utilizing 10 level-1 trauma centers designed to determine the efficacy and safety of low titer whole blood resuscitation as compared to standard of care resuscitation in patients at risk of hemorrhagic shock and to appropriately characterize the hemostatic competency of whole blood relative to its age.
Primary Outcome
All cause mortality within 30 days
Conditions Studied
Interventions
- BIOLOGICAL low titer whole blood
- BIOLOGICAL Standard Care
Study Locations (10)
Ohio
- University of Cincinatti - Cincinnati
- Metrohealth Systems - Cleveland
Tennessee
- University of Tennessee Medical Center - Knoxville
- Vanderbilt University Medical Center - Nashville
Alabama
- University of Alabama at Birmingham - Birmingham
Kentucky
- University of Louisville - Louisville
Mississippi
- University of Mississippi Medical Center (UMMC) - Jackson
Pennsylvania
- University of Pittsburgh - Pittsburgh
Texas
- University of Texas Health Science Center at Houston - Houston
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,020 participants |
| Start Date | 2022-04-19 |
| Est. Completion | 2025-08-12 |
| Phase | Phase 3 |
What the finished NCT04684719 record still lists
NCT04684719 is an interventional study that assigns participants to a tested intervention. Its 1,020 participants enrollment target places it among the larger protocols in the corpus, above the 294-participant average among 7 other Traumatic Injury trials with a reported enrollment target (247% higher).
The record links to 2 conditions, with Traumatic Injury appearing as the primary indexed condition, and to 2 interventions - of which low titer whole blood is the first listed.
NCT04684719 lists 10 locations in 8 states (Ohio, Tennessee, Alabama).
Frequently Asked Questions
What is clinical trial NCT04684719 about?
NCT04684719 is a clinical study titled "Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial". Open label, multi-center, pre-hospital randomized trial utilizing 10 level-1 trauma centers designed to determine the efficacy and safety of low titer whole blood resuscitation as compared to standard of care resuscitation in patients at risk of hemorrhagic shock and to appropriately characterize th...
What is the current status of trial NCT04684719?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,020 participants. The study started on 2022-04-19. Estimated completion is 2025-08-12.
What conditions does trial NCT04684719 study?
This clinical trial studies the following conditions: Traumatic Injury, Hemorrhagic Shock.
What interventions are being tested in trial NCT04684719?
The interventions under investigation include: low titer whole blood (BIOLOGICAL), Standard Care (BIOLOGICAL).
Who is sponsoring clinical trial NCT04684719?
This trial is sponsored by Jason Sperry, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04684719 being conducted?
This trial has 10 study locations across Alabama, Kentucky, Mississippi, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prehospital Analgesia INtervention Trial (PAIN)
RECRUITING · Phase 3
-
DSUVIA Early Evaluation of Pain Trial
COMPLETED · Phase 3
-
Advancing Discussions Using a Video-based Support Tool About End-of-life Care
RECRUITING · NA
-
Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
RECRUITING · NA
-
Pediatric and Caregiver Traumatic Stress Intervention (PACTS)
RECRUITING · NA
-
Evaluation of Trauma Center-Based Intervention for Adolescent Traumatic Injury Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02178163 · 1,020 participants · NA
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
- NCT05225428 · 1,020 participants · NA
Video Education With Result Dependent dIsclosure
- NCT06697600 · 1,020 participants · NA
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
- NCT06760637 · 1,020 participants · Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI